NYSEARCA:FBT First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free FBT Stock Alerts $151.35 -0.37 (-0.24%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$151.14▼$152.3850-Day Range$145.08▼$160.4652-Week Range$130.27▼$161.41Volume20,651 shsAverage Volume31,061 shsMarket Capitalization$1.38 billionAssets Under Management$1.20 billionDividend Yield0.00%Net Expense Ratio0.55% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get First Trust NYSE Arca Biotechnology Index Fund alerts: Email Address About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.Read More FBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FBT ETF News HeadlinesJanuary 6, 2024 | theglobeandmail.comClosing Bell: First Trust NYSE Arca Biotechnology ETF up on Friday (FBT)January 6, 2024 | theglobeandmail.comClosing Bell: First Trust NYSE Arca Biotechnology ETF flat on Friday (FBT)March 18, 2024 | Paradigm Press (Ad)8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: October 23, 2023 | benzinga.comFirst Trust Dynamic Europe Equity Income Fund Declares its Monthly Common Share Distribution of $0.07 Per Share for NovemberSeptember 29, 2023 | wsj.comNYSE Arca Major Market IndexApril 27, 2023 | seekingalpha.comFBT First Trust NYSE Arca Biotechnology Index Fund ETFMarch 17, 2023 | wsj.comNYSE Arca Securities Broker/Dealer IndexMarch 11, 2023 | wsj.comNYSE Arca Gold BUGS IndexMarch 18, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.October 22, 2022 | fool.comFirst Trust NYSE Arca Biotechnology Index Fund (NYSEMKT: FBT)See More Headlines Receive FBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFirst Trust Fund NameFirst Trust NYSE Arca Biotechnology Index Fund Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:FBT Inception Date6/19/2006 Fund ManagerDaniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE Arca Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings32 Fund Statistics Assets Under Management$1.20 billion Average Daily Volume$12,306.40 Discount/Premium-0.09% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableOptionable Options Volume1 Put Options1 Call Options1 Miscellaneous Outstanding Shares9,100,000Beta0.79 Creation Unit50,000 Creation Fee$500.00 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now First Trust NYSE Arca Biotechnology Index Fund ExpensesTypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.40%0.57%0.54%0.50%0.51%Other Expenses0.15%0.40%0.54%0.64%0.58%Total Expense0.55%0.72%0.70%0.73%0.70%Fee Waiver0.00%-0.53%-0.54%-0.68%-0.56%Net Expense0.55%0.61%0.60%0.57%0.58% First Trust NYSE Arca Biotechnology Index Fund (FBT) Holdings & ExposureTop 10 FBT HoldingsRegeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 3.63%Amgen(NASDAQ:AMGN)Holding Weight: 3.61%Exelixis(NASDAQ:EXEL)Holding Weight: 3.58%Neurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 3.58%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 3.51%Charles River Laboratories International(NYSE:CRL)Holding Weight: 3.49%Grifols(NASDAQ:GRFS)Holding Weight: 3.48%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 3.46%Seagen(NASDAQ:SGEN)Holding Weight: 3.46%Incyte(NASDAQ:INCY)Holding Weight: 3.45%FBT Sector ExposureFBT Industry ExposureFull Holdings Details Similar ETFsDirexion Daily S&P Biotech Bull 3x SharesNYSEARCA:LABUFirst Trust Health Care AlphaDEX FundNYSEARCA:FXHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RSPHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RYHiShares U.S. Healthcare Providers ETFNYSEARCA:IHFInstitutional OwnershipB. Riley Wealth Advisors Inc.Sold 12,634 shares on 3/15/2024Ownership: 0.087%Novak & Powell Financial Services Inc.Bought 1,710 shares on 2/21/2024Ownership: 0.019%Harbour Investments Inc.Sold 1,044 shares on 2/16/2024Ownership: 0.080%Virtue Capital Management LLCSold 67 shares on 2/15/2024Ownership: 0.021%Dagco Inc.Bought 318 shares on 2/15/2024Ownership: 0.003%View All Institutional Transactions FBT ETF - Frequently Asked Questions How have FBT shares performed in 2024? First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $158.06 on January 1st, 2024. Since then, FBT shares have decreased by 4.2% and is now trading at $151.35. View the best growth stocks for 2024 here. What does FBT invest in? First Trust NYSE Arca Biotechnology Index Fund is a equity fund issued by First Trust. FBT focuses on health care investments and follows the NYSE Arca Biotechnology Index. The fund's investments total to approximately $1.20 billion assets under management. What stocks does First Trust NYSE Arca Biotechnology Index Fund hold? FBT invests in 32 holdings. Some of the stocks in their portfolio include Regeneron Pharmaceuticals (REGN), Amgen (AMGN), Exelixis (EXEL), Neurocrine Biosciences (NBIX), BioMarin Pharmaceutical (BMRN), Charles River Laboratories International (CRL), Grifols (GRFS), Sarepta Therapeutics (SRPT), Seagen (SGEN) and Incyte (INCY). What is the management fee for First Trust NYSE Arca Biotechnology Index Fund? First Trust NYSE Arca Biotechnology Index Fund's management fee is 0.40% and has other expenses of 0.15%. The net expense ratio for FBT is 0.55%. What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own? Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology Index Fund investors own include Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Walt Disney (DIS), Annaly Capital Management (NLY), ONEOK (OKE), Valero Energy (VLO), AbbVie (ABBV), Broadcom (AVGO) and Bristol-Myers Squibb (BMY). Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders? First Trust NYSE Arca Biotechnology Index Fund's stock is owned by a variety of retail and institutional investors. Top institutional investors include Wells Fargo & Company MN (4.35%), UBS Group AG (2.52%), Royal Bank of Canada (2.44%), Raymond James Financial Services Advisors Inc. (2.20%), International Assets Investment Management LLC (2.03%) and Raymond James & Associates (1.37%). How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund? Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:FBT) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.